Stocktoria
Vaxart, Inc. VXRT
OTC · OOTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1980-03-17
Vaxart, Inc. statistics & valuation
Market cap$136.1M
P / E8.3×
P / S0.6×
P / B1.6×
P / FCF18.0×
Net margin6.9%
Return on equity18.6%
FCF margin3.2%
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 7.6% | -231.0% | -1129.5% | -107090.7% | -8156.1% | -745.7% | -160.1% | -523.1% | -171.5% | -309.0% |
| Net margin | 6.9% | -233.3% | -1117.6% | -100708.4% | -7900.2% | -796.3% | -189.1% | -433.0% | -164.1% | -330.3% |
| FCF margin | 3.2% | -157.9% | -980.1% | -97551.4% | -7285.8% | -617.2% | -141.4% | -366.8% | -174.0% | — |
| Return on assets | 8.8% | -40.2% | -89.8% | -70.0% | -31.9% | -21.1% | -50.3% | -51.1% | -211.9% | -73.3% |
| Return on equity | 18.6% | -113.6% | -142.7% | -97.4% | -37.6% | -26.1% | -144.0% | -160.6% | 24.7% | -157.2% |
| Debt / equity | — | — | — | — | — | — | — | 1.58× | -0.41× | — |
| Current ratio | 1.57 | 0.75 | 3.32 | 5.55 | 15.69 | 10.93 | 1.92 | 1.96 | 0.83 | 6.76 |
Source: SEC EDGAR filings · CIK 0000072444 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.